A Rare Case of Double-antibody-positive Renal Vasculitis: Are we in a Hurry to Start Tuberculosis Medicines?
Sunil Kumar,Ankita Kumari,Jimit N. Mistry,Mohit Naredi,Ayushi Chander
DOI: https://doi.org/10.4103/jalh.jalh_27_23
2024-03-29
Journal of Advanced Lung Health
Abstract:The antiglomerular basement membrane (GBM) disease is a rare kind of small-vessel vasculitis, characterized by the involvement of renal and pulmonary capillary beds along with the presence of anti-GBM antibodies. It results from environmental insults in a person with a genetic predisposition. The environmental agents include drugs such as alemtuzumab, inhalation of cocaine, influenza A2 infection, smoking and exposure to metal dust, organic solvents, and hydrocarbons. [ 1 , 2 ] Around one-third of patients with anti-GBM antibodies also have a second antibody as well, i.e., antineutrophil cytoplasmic antibody (ANCA). This so-called double-antibody-positive renal vasculitis is associated with poor outcomes. [ 3 ]
What problem does this paper attempt to address?